XAIR Beyond Air Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: XAIR

Price (delayed)

$5.16

Market cap

$3.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$80

Enterprise value

$14.74M

?
Relative Growth: Rel. Growth: 70
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: 38
Relative Profitability: Rel. Profitability: 11

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit™, that uses NO generated from ambient air to deliver precise ...

Highlights
XAIR's gross profit has soared by 115% year-on-year and by 100% since the previous quarter
XAIR's revenue has surged by 107% year-on-year and by 11% since the previous quarter
The company's quick ratio has surged by 80% YoY but it fell by 26% QoQ
The company's net income rose by 29% YoY but it fell by 7% QoQ
The debt has soared by 100% year-on-year
Beyond Air's equity has shrunk by 55% YoY and by 24% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.ait-pharm.com
Peers: OFIX

Key stats

What are the main financial stats of XAIR

XAIR stock price

How has the Beyond Air stock price performed over time
Intraday
-5.67%
1 week
-7.53%
1 month
-46.14%
1 year
-92.23%
YTD
-64.46%
QTD
-42.15%

Financial performance

How have Beyond Air's revenue and profit performed over time
Revenue
$7.68M
Gross profit
$252,000
Operating income
-$29.04M
Net income
-$33.25M
Gross margin
3.3%
Net margin
-433%
XAIR's gross profit has soared by 115% year-on-year and by 100% since the previous quarter
XAIR's revenue has surged by 107% year-on-year and by 11% since the previous quarter
The company's gross margin has surged by 107% YoY and by 83% QoQ
Beyond Air's operating margin has surged by 69% YoY and by 10% QoQ

Price vs fundamentals

How does XAIR's price correlate with its fundamentals

Growth

What is Beyond Air's growth rate over time

Valuation

What is Beyond Air stock price valuation
P/E
N/A
P/B
0.44
P/S
0.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.92
XAIR's EPS has surged by 71% year-on-year and by 14% since the previous quarter
The stock's price to book (P/B) is 83% less than its 5-year quarterly average of 2.6 and 60% less than its last 4 quarters average of 1.1
Beyond Air's equity has shrunk by 55% YoY and by 24% QoQ
XAIR's revenue has surged by 107% year-on-year and by 11% since the previous quarter
The price to sales (P/S) is 85% lower than the last 4 quarters average of 1.9

Efficiency

How efficient is Beyond Air business performance
XAIR's return on sales has surged by 67% year-on-year and by 4.7% since the previous quarter
Beyond Air's ROE has decreased by 46% YoY and by 29% from the previous quarter
The company's return on invested capital rose by 34% YoY
XAIR's return on assets is up by 11% year-on-year but it is down by 2.8% since the previous quarter

Dividends

What is XAIR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XAIR.

Financial health

How did Beyond Air financials performed over time
The total assets is 21% more than the total liabilities
Beyond Air's total liabilities has surged by 86% YoY and by 2.4% QoQ
The company's quick ratio has surged by 80% YoY but it fell by 26% QoQ
The debt has soared by 100% year-on-year
Beyond Air's equity has shrunk by 55% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.